Loading...
Merrimack Pharmaceuticals, Inc.
MACK•NASDAQ
HealthcareBiotechnology
$15.14
$0.01(0.10%)
Merrimack Pharmaceuticals, Inc. (MACK) Stock Overview
Explore Merrimack Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for MACKStats details for MACK are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for MACKAnalyst Recommendations details for MACK are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
CEO
0Mr. Gary L. Crocker M.B.A.
Headquarters
One Broadway, Cambridge, MA
Founded
2012